The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Tumor evolution: Linear, branching, neutral or punctuated?
Open accessAbstract
Intratumor heterogeneity has been widely reported in human cancers, but our knowledge of how this genetic diversity emerges over time remains limited. A central challenge in studying tumor evolution is the difficulty in collecting longitudinal samples from cancer patients. Consequently, most studies have inferred tumor evolution from single time-point samples, providing very indirect information. These data have led to several competing models of tumor evolution: linear, branching, neutral and punctuated. Each model makes different assumptions regarding the timing of mutations and selection of clones, and therefore has different implications for the diagnosis and therapeutic treatment of cancer patients. Furthermore, emerging evidence suggests that models may change during tumor progression or operate concurrently for different classes of mutations. Finally, we discuss data that supports the theory that most human tumors evolve from a single cell in the normal tissue. This article is part of a Special Issue entitled: Evolutionary principles - heterogeneity in cancer?, edited by Dr. Robert A. Gatenby.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 3×
“These studies have reported branching evolution in many human cancers, including leukemia [57,66] breast cancer [17,18,28,61], liver cancer [68], colorectal cancer [58,69,70], ovarian cancer [24,71], prostate cancer [64], kidney cancer [21,23], melanoma [72] and brain cancer [62,63,73].”
BackgroundNowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Punctuated equilibria: an alternative to phyletic gradualism
Eldredge, N., Gould, S. J., & Schöpf, T. J. M. (1972) · Cited by 3,257
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Self-citationDistant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Ding, L., Ley, T. J., Larson, D. E., Miller, C. A., Koboldt, D. C., Welch, J. S., Ritchey, J. K., Young, M. A., Lamprecht, T., McLellan, M. D., et al. (2012) · Nature · doi:10.1038/nature10738 · Cited by 1,993
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
High burden and pervasive positive selection of somatic mutations in normal human skin
Martincorena, I., Roshan, A., Gerstung, M., Ellis, P., Van Loo, P., McLaren, S., Wedge, D. C., Fullam, A., Alexandrov, L. B., Tubio, J. M., et al. (2015) · Science · doi:10.1126/science.aaa6806 · Cited by 1,770
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Hidalgo, M., Amant, F., Biankin, A. V., Budinská, E., Byrne, A. T., Caldas, C., Clarke, R. B., de Jong, S., Jonkers, J., Mælandsmo, G. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0001 · Cited by 1,742
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Sottoriva, A., Spiteri, I., Piccirillo, S. G. M., Touloumis, A., Collins, V. P., Marioni, J. C., Curtis, C., Watts, C., & Tavaré, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219747110 · Cited by 1,737
Cancer as an evolutionary and ecological process
Merlo, L. M. F., Pepper, J. W., Reid, B. J., & Maley, C. C. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2013 · Cited by 1,699
Tumor heterogeneity: Causes and consequences
Marusyk, A., & Polyak, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.002 · Cited by 1,602
Whole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
The anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397
Punctuated Evolution of Prostate Cancer Genomes
Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.021 · Cited by 1,320
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Gerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208
Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell
Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012) · Science · doi:10.1126/science.1229164 · Cited by 1,154
Chromothripsis from DNA damage in micronuclei
Zhang, C.-Z., Spektor, A., Cornils, H., Francis, J. M., Jackson, E. K., Liu, S., Meyerson, M., & Pellman, D. (2015) · Nature · doi:10.1038/nature14493 · Cited by 1,148
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
de Bruin, E. C., McGranahan, N., Mitter, R., Salm, M., Wedge, D. C., Yates, L., Jamal-Hanjani, M., Shafi, S., Murugaesu, N., Rowan, A. J., et al. (2014) · Science · doi:10.1126/science.1253462 · Cited by 1,117
Advances in understanding cancer genomes through second-generation sequencing
Meyerson, M., Gabriel, S., & Getz, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2841 · Cited by 1,116
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution
McGranahan, N., & Swanton, C. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.001 · Cited by 1,077
Moran, P. A. P. (1958) · Mathematical Proceedings of the Cambridge Philosophical Society · doi:10.1017/s0305004100033193 · Cited by 1,065
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Wang, Y., Waters, J., Leung, M. L., Unruh, A., Roh, W., Shi, X., Chen, K., Scheet, P., Vattathil, S., Liang, H., et al. (2014) · Nature · doi:10.1038/nature13600 · Cited by 1,029
Self-citationA Big Bang model of human colorectal tumor growth
Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., Marjoram, P., Siegmund, K., Press, M. F., Shibata, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3214 · Cited by 1,015
PyClone: statistical inference of clonal population structure in cancer
Roth, A., Khattra, J., Yap, D., Wan, A., Laks, E., Biele, J., Ha, G., Aparicio, S., Bouchard-Côté, A., & Shah, S. P. (2014) · Nature Methods · doi:10.1038/nmeth.2883 · Cited by 999
Cancer heterogeneity: implications for targeted therapeutics
Fisher, R., Pusztai, L., & Swanton, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.581 · Cited by 978
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Zhang, J., Fujimoto, J., Zhang, J., Wedge, D. C., Song, X., Zhang, J., Seth, S., Chow, C.-W., Cao, Y., Gumbs, C., et al. (2014) · Science · doi:10.1126/science.1256930 · Cited by 965
Punctuated equilibrium comes of age
Gould, S. J., & Eldredge, N. (1993) · Nature · doi:10.1038/366223a0 · Cited by 957
A decade’s perspective on DNA sequencing technology
Mardis, E. R. (2011) · Nature · doi:10.1038/nature09796 · Cited by 916
Gatenby, R. A., Silva, A. S., Gillies, R. J., & Frieden, B. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3658 · Cited by 846
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
Kimura, M. (1969) · Genetics · doi:10.1093/genetics/61.4.893 · Cited by 817
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Yates, L. R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Van Loo, P., Aas, T., Alexandrov, L. B., Larsimont, D., Davies, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3886 · Cited by 816
Causes and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B., & Pellman, D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 815
Accumulation of driver and passenger mutations during tumor progression
Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., Karchin, R., Kinzler, K. W., Vogelstein, B., & Nowak, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010978107 · Cited by 795
Toward understanding and exploiting tumor heterogeneity
Alizadeh, A. A., Aranda, V., Bardelli, A., Blanpain, C., Bock, C., Borowski, C., Caldas, C., Califano, A., Doherty, M., Elsner, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3915 · Cited by 746
Self-citationLanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695
Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor
Xu, X., Hou, Y., Yin, X., Bao, L., Tang, A., Song, L., Li, F., Tsang, S., Wu, K., Wu, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.025 · Cited by 667
Identification of neutral tumor evolution across cancer types
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A., & Sottoriva, A. (2016) · Nature Genetics · doi:10.1038/ng.3489 · Cited by 625
Advances and Applications of Single-Cell Sequencing Technologies
Wang, Y., & Navin, N. E. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.005 · Cited by 618
Self-citationDynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Eirew, P., Steif, A., Khattra, J., Ha, G., Yap, D., Farahani, H., Gelmon, K., Chia, S., Mar, C., Wan, A., et al. (2015) · Nature · doi:10.1038/nature13952 · Cited by 598
Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
Marusyk, A., Tabassum, D. P., Altrock, P. M., Almendro, V., Michor, F., & Polyak, K. (2014) · Nature · doi:10.1038/nature13556 · Cited by 597
Inda, M.-D.-M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D. W. Y., Vandenberg, S., Brennan, C., Johns, T. G., Bachoo, R., Hadwiger, P., et al. (2010) · Genes & Development · doi:10.1101/gad.1890510 · Cited by 543
Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm
Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., Li, F., Wu, K., Liang, J., Shao, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.028 · Cited by 541
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Lohr, J. G., Adalsteinsson, V. A., Cibulskis, K., Choudhury, A. D., Rosenberg, M., Cruz-Gordillo, P., Francis, J. M., Zhang, C.-Z., Shalek, A. K., Satija, R., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2892 · Cited by 535
Inferring tumor progression from genomic heterogeneity
Navin, N., Krasnitz, A., Rodgers, L., Cook, K., Meth, J., Kendall, J., Riggs, M., Eberling, Y., Troge, J., Grubor, V., et al. (2010) · Genome Research · doi:10.1101/gr.099622.109 · Cited by 524
Self-citationPunctuated copy number evolution and clonal stasis in triple-negative breast cancer
Gao, R., Davis, A., McDonald, T. O., Sei, E., Shi, X., Wang, Y., Tsai, P.-C., Casasent, A., Waters, J., Zhang, H., et al. (2016) · Nature Genetics · doi:10.1038/ng.3641 · Cited by 523
Self-citationIntratumor Heterogeneity: Seeing the Wood for the Trees
Yap, T. A., Gerlinger, M., Futreal, P. A., Pusztai, L., & Swanton, C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003854 · Cited by 490
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity
Waclaw, B., Bozic, I., Pittman, M. E., Hruban, R. H., Vogelstein, B., & Nowak, M. A. (2015) · Nature · doi:10.1038/nature14971 · Cited by 486
Murtaza, M., Dawson, S.-J., Pogrebniak, K., Rueda, O. M., Provenzano, E., Grant, J., Chin, S.-F., Tsui, D. W. Y., Marass, F., Gale, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9760 · Cited by 483
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Boutros, P. C., Fraser, M., Harding, N. J., de Borja, R., Trudel, D., Lalonde, E., Meng, A., Hennings-Yeomans, P. H., McPherson, A., Sabelnykova, V. Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3315 · Cited by 477
Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
Cleary, A. S., Leonard, T. L., Gestl, S. A., & Gunther, E. J. (2014) · Nature · doi:10.1038/nature13187 · Cited by 465
Ni, X., Zhuo, M., Su, Z., Duan, J., Gao, Y., Wang, Z., Zong, C., Bai, H., Chapman, A. R., Zhao, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320659110 · Cited by 454
Miller, C. A., White, B. S., Dees, N. D., Griffith, M., Welch, J. S., Griffith, O. L., Vij, R., Tomasson, M. H., Graubert, T. A., Walter, M. J., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003665 · Cited by 454
Antonia, S. J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Bepler, G., Simon, G., Janssen, W., Lee, J.-H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2013 · Cited by 444
Bashashati, A., Ha, G., Tone, A., Ding, J., Prentice, L. M., Roth, A., Rosner, J., Shumansky, K., Kalloger, S., Senz, J., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4230 · Cited by 421
PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors
Deshwar, A. G., Vembu, S., Yung, C. K., Jang, G. H., Stein, L., & Morris, Q. (2015) · Genome Biology · doi:10.1186/s13059-015-0602-8 · Cited by 418
Evolving responsively: adaptive mutation
Rosenberg, S. M. (2001) · Nature Reviews Genetics · doi:10.1038/35080556 · Cited by 417
Genetic Progression and the Waiting Time to Cancer
Beerenwinkel, N., Antal, T., Dingli, D., Traulsen, A., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., & Nowak, M. A. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030225 · Cited by 408
Human cancers express mutator phenotypes: origin, consequences and targeting
Loeb, L. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3063 · Cited by 396
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 395
Branching Processes in Biology
Kimmel, M., & Axelrod, D. E. (2015) · Interdisciplinary Applied Mathematics · doi:10.1007/978-1-4939-1559-0 · Cited by 387
Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing
Campbell, P. J., Pleasance, E. D., Stephens, P. J., Dicks, E., Rance, R., Goodhead, I., Follows, G. A., Green, A. R., Futreal, P. A., & Stratton, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801523105 · Cited by 365
Ling, S., Hu, Z., Yang, Z., Yang, F., Li, Y., Lin, P., Chen, K., Dong, L., Cao, L., Tao, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519556112 · Cited by 352
Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer
McPherson, A., Roth, A., Laks, E., Masud, T., Bashashati, A., Zhang, A. W., Ha, G., Biele, J., Yap, D., Wan, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3573 · Cited by 340
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
Enriquez-Navas, P. M., Kam, Y., Das, T., Hassan, S., Silva, A., Foroutan, P., Ruiz, E., Martinez, G., Minton, S., Gillies, R. J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7842 · Cited by 322
Novel patterns of genome rearrangement and their association with survival in breast cancer
Hicks, J., Krasnitz, A., Lakshmi, B., Navin, N. E., Riggs, M., Leibu, E., Esposito, D., Alexander, J., Troge, J., Grubor, V., et al. (2006) · Genome Research · doi:10.1101/gr.5460106 · Cited by 319
Self-citationCancer genomics: one cell at a time
Navin, N. E. (2014) · Genome Biology · doi:10.1186/s13059-014-0452-9 · Cited by 318
Self-citationTherapeutic targets in cancer cell metabolism and autophagy
Cheong, H., Lu, C., Lindsten, T., & Thompson, C. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2285 · Cited by 315
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
He, J., Abdel-Wahab, O., Nahas, M. K., Wang, K., Rampal, R. K., Intlekofer, A. M., Patel, J., Krivstov, A., Frampton, G. M., Young, L. E., et al. (2016) · Blood · doi:10.1182/blood-2015-08-664649 · Cited by 311
Glycolysis in cancer: A potential target for therapy
Gatenby, R. A., & Gillies, R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.021 · Cited by 304
Tree inference for single-cell data
Jahn, K., Kuipers, J., & Beerenwinkel, N. (2016) · Genome Biology · doi:10.1186/s13059-016-0936-x · Cited by 302
Dissecting the clonal origins of childhood acute lymphoblastic leukemia by single-cell genomics
Gawad, C., Koh, W., & Quake, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420822111 · Cited by 281
Almendro, V., Cheng, Y.-K., Randles, A., Itzkovitz, S., Marusyk, A., Ametller, E., Gonzalez-Farre, X., Muñoz, M., Russnes, H. G., Helland, Å., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.041 · Cited by 274
Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements
Zhang, C.-Z., Leibowitz, M. L., & Pellman, D. (2013) · Genes & Development · doi:10.1101/gad.229559.113 · Cited by 250
Clonality inference in multiple tumor samples using phylogeny
Malikic, S., McPherson, A. W., Donmez, N., & Sahinalp, C. S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv003 · Cited by 248
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
Jamal-Hanjani, M., Hackshaw, A., Ngai, Y., Shaw, J., Dive, C., Quezada, S., Middleton, G., de Bruin, E., Le Quesne, J., Shafi, S., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001906 · Cited by 247
DNA Microarrays: a Powerful Genomic Tool for Biomedical and Clinical Research
Trevino, V., Falciani, F., & Barrera-Saldaña, H. A. (2007) · Molecular Medicine · doi:10.2119/2006-00107.trevino · Cited by 245
Inferring clonal evolution of tumors from single nucleotide somatic mutations
Jiao, W., Vembu, S., Deshwar, A. G., Stein, L., & Morris, Q. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-35 · Cited by 236
Fast and scalable inference of multi-sample cancer lineages
Popic, V., Salari, R., Hajirasouliha, I., Kashef-Haghighi, D., West, R. B., & Batzoglou, S. (2015) · Genome Biology · doi:10.1186/s13059-015-0647-8 · Cited by 229
Field effect in cancer-an update.
Chai, H., & Brown, R. E. (2009) · PubMed · Cited by 223
OncoNEM: inferring tumor evolution from single-cell sequencing data
Ross, E. M., & Markowetz, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0929-9 · Cited by 222
Genetic demixing and evolution in linear stepping stone models
Korolev, K. S., Avlund, M., Hallatschek, O., & Nelson, D. R. (2010) · Reviews of Modern Physics · doi:10.1103/revmodphys.82.1691 · Cited by 221
Reconstruction of clonal trees and tumor composition from multi-sample sequencing data
El-Kebir, M., Oesper, L., Acheson-Field, H., & Raphael, B. J. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv261 · Cited by 221
Mroz, E. A., Tward, A. D., Pickering, C. R., Myers, J. N., Ferris, R. L., & Rocco, J. W. (2013) · Cancer · doi:10.1002/cncr.28150 · Cited by 220
The Origins and Implications of Intratumor Heterogeneity
Michor, F., & Polyak, K. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0234 · Cited by 209
The Origin and Development of Human Tumors Studied with Cell Markers
Fialkow, P. J. (1974) · New England Journal of Medicine · doi:10.1056/nejm197407042910109 · Cited by 209
Chromothripsis: A New Mechanism for Rapid Karyotype Evolution
Leibowitz, M. L., Zhang, C.-Z., & Pellman, D. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092228 · Cited by 205
Kloosterman, W. P., Hoogstraat, M., Paling, O., Tavakoli-Yaraki, M., Renkens, I., Vermaat, J. S., van Roosmalen, M. J., van Lieshout, S., Nijman, I. J., Roessingh, W., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-10-r103 · Cited by 204
Metapopulation dynamics and spatial heterogeneity in cancer
González-García, I., Solé, R. V., & Costa, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202139299 · Cited by 201
Hoffman, L. M., DeWire, M., Ryall, S., Buczkowicz, P., Leach, J., Miles, L., Ramani, A., Brudno, M., Kumar, S. S., Drissi, R., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0269-0 · Cited by 199
Meric-Bernstam, F., Brusco, L., Daniels, M., Wathoo, C., Bailey, A. M., Strong, L., Shaw, K., Lu, K., Qi, Y., Zhao, H., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw018 · Cited by 195
The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
Kopetz, S., Lemos, R., & Powis, G. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2408 · Cited by 176
Application of Evolutionary Principles to Cancer Therapy
Enriquez-Navas, P. M., Wojtkowiak, J. W., & Gatenby, R. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1337 · Cited by 175
Metronomic Chemotherapy: Changing the Paradigm That More Is Better
Scharovsky, O. G., Mainetti, L. E., & Rozados, V. R. (2009) · Current Oncology · doi:10.3747/co.v16i2.420 · Cited by 173
Phylogenetic Quantification of Intra-tumour Heterogeneity
Schwarz, R. F., Trinh, A., Sipos, B., Brenton, J. D., Goldman, N., & Markowetz, F. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003535 · Cited by 167
Kim, T.-M., Jung, S.-H., An, C. H., Lee, S. H., Baek, I.-P., Kim, M. S., Park, S.-W., Rhee, J.-K., Lee, S.-H., & Chung, Y.-J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2413 · Cited by 161
Merlo, L. M. F., Shah, N. A., Li, X., Blount, P. L., Vaughan, T. L., Reid, B. J., & Maley, C. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0108 · Cited by 155
Navin, N. E., & Hicks, J. B. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.010 · Cited by 152
Self-citationLi, Y., Xu, X., Song, L., Hou, Y., Li, Z., Tsang, S. X., Li, F., McGee, K., Wu, K., Wu, H., et al. (2012) · GigaScience · doi:10.1186/2047-217x-1-12 · Cited by 136
Intratumor Heterogeneity in Evolutionary Models of Tumor Progression
Durrett, R., Foo, J., Leder, K., Mayberry, J. K., & Michor, F. (2011) · Genetics · doi:10.1534/genetics.110.125724 · Cited by 134
TrAp: a tree approach for fingerprinting subclonal tumor composition
Strino, F., Parisi, F., Micsinai, M., & Kluger, Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt641 · Cited by 126
Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing
Yu, C., Yu, J. Q., Yao, X., Wu, W. K. K., Lu, Y., Tang, S., Li, X., Bao, L., Li, X., Hou, Y., et al. (2014) · Cell Research · doi:10.1038/cr.2014.43 · Cited by 124
Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution
Božić, I., Gerold, J. M., & Nowak, M. A. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004731 · Cited by 124
Szöllõsi, J., Balázs, M., Feuerstein, B. G., Benz, C. C., & Waldman, F. M. (1995) · PubMed · Cited by 121
BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies
Yuan, K., Sakoparnig, T., Markowetz, F. M., & Beerenwinkel, N. (2015) · Genome biology · doi:10.1186/s13059-015-0592-6 · Cited by 119
Rare variant alleles in the light of the neutral theory.
Kimura, M. (1984) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040305 · Cited by 119
Polański, A., & Kimmel, M. (2003) · Genetics · doi:10.1093/genetics/165.1.427 · Cited by 113
Clonal genotype and population structure inference from single-cell tumor sequencing
Roth, A. J. L., McPherson, A., Laks, E., Biele, J., Yap, D., Wan, A., Smith, M. A., Nielsen, C. B., McAlpine, J. N., Aparicio, S. A. J. R., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3867 · Cited by 113
Butler, T. M., Johnson-Camacho, K., Peto, M., Wang, N. J., Macey, T. A., Korkola, J. E., Koppie, T. M., Corless, C. L., Gray, J. W., & Spellman, P. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136407 · Cited by 111
Harbst, K., Lauss, M., Cirenajwis, H., Isaksson, K., Rosengren, F., Törngren, T., Kvist, A., Johansson, M. C., Vallon‐Christersson, J., Baldetorp, B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3476 · Cited by 110
Genome evolution during progression to breast cancerPreprint
Newburger, D. E., Kashef-Haghighi, D., Weng, Z., Salari, R., Sweeney, R. T., Brunner, A. L., Zhu, S., Guo, X., Varma, S., Troxell, M. L., et al. (2013) · Genome Research · doi:10.1101/gr.151670.112 · Cited by 108
Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome
Venkatesan, S., & Swanton, C. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_158930 · Cited by 107
Hajirasouliha, I., Mahmoody, A., & Raphael, B. J. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu284 · Cited by 106
Letouzé, É., Allory, Y., Bollet, M. A., Radvanyi, F., & Guyon, F. (2010) · Genome biology · doi:10.1186/gb-2010-11-7-r76 · Cited by 101
Many different tumor types have polyclonal tumor origin: Evidence and implications
Parsons, B. L. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.05.004 · Cited by 95
From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
Aubry, M., de Tayrac, M., Etcheverry, A., Clavreul, A., Saïkali, S., Meneï, P., & Mosser, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3297 · Cited by 92
DePinho, R. A., & Polyak, K. (2004) · Nature Genetics · doi:10.1038/ng0904-932 · Cited by 91
Pellman, D. S. (2007) · Nature · doi:10.1038/446038a · Cited by 84
Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
Cooke, S. L., Temple, J., MacArthur, S., Zahra, M., Tan, L. T., Crawford, R., Ng, C. K. Y., Jimenez‐Liñan, M., Sala, E., & Brenton, J. D. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605971 · Cited by 76
Zhang, L., Strouthos, C., Wang, Z., & Deisboeck, T. S. (2008) · Mathematical and Computer Modelling · doi:10.1016/j.mcm.2008.05.011 · Cited by 76
Evolutionary Dynamics in Cancer Therapy
Cunningham, J. J., Gatenby, R. A., & Brown, J. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2002279 · Cited by 76
Mutator phenotype in cancer: Timing and perspectives
Bielas, J. H., & Loeb, L. A. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20111 · Cited by 73
Kimmel, M., & Axelrod, D. E. (1990) · Genetics · doi:10.1093/genetics/125.3.633 · Cited by 69
Stochastic dynamics of cancer initiation
Foo, J., Leder, K., & Michor, F. (2011) · Physical Biology · doi:10.1088/1478-3975/8/1/015002 · Cited by 64
Establishment and Genomic Characterization of Mouse Xenografts of Human Primary Prostate Tumors
Priolo, C., Agostini, M., Vena, N., Ligon, A. H., Fiorentino, M., Shin, E., Farsetti, A., Pontecorvi, A., Sicińska, E., & Loda, M. F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090873 · Cited by 64
Qiao, Y., Quinlan, A. R., Jazaeri, A. A., Verhaak, R. G. W., Wheeler, D. A., & Marth, G. (2014) · Genome biology · doi:10.1186/preaccept-1691129011290725 · Cited by 64
Concepts in solid tumor evolution
Sidow, A., & Spies, N. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.02.001 · Cited by 60
Resistance to Chemotherapy: Patient Variability and Cellular Heterogeneity
Kessler, D. A., Austin, R. H., & Levine, H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0118 · Cited by 59
Interfering Waves of Adaptation Promote Spatial Mixing
Martens, E. A., & Hallatschek, O. (2011) · Genetics · doi:10.1534/genetics.111.130112 · Cited by 54
Re-Evaluating Clonal Dominance in Cancer Evolution
Burrell, R. A., & Swanton, C. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.04.002 · Cited by 54
Metronomics as Maintenance Treatment in Oncology: Time for Chemo-Switch
Malik, P. S., Raina, V., & André, N. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00076 · Cited by 39
Can oncology recapitulate paleontology? Lessons from species extinctions
Walther, V., Hiley, C. T., Shibata, D. K., Swanton, C., Turner, P. E., & Maley, C. C. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.12 · Cited by 37
Many private mutations originate from the first few divisions of a human colorectal adenoma
Kang, H., Salomon, M. P., Sottoriva, A., Zhao, J., Toy, M., Press, M. F., Curtis, C. N., Marjoram, P., Siegmund, K. D., & Shibata, D. K. (2015) · The Journal of Pathology · doi:10.1002/path.4581 · Cited by 32
Next-Generation Sequence Analysis of Cancer Xenograft Models
Rossello, F. J., Tothill, R. W., Britt, K. L., Marini, K. D., Falzon, J., Thomas, D. M., Peacock, C. D., Marchionni, L., Li, J., Bennett, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074432 · Cited by 31
Giehr, P., Kyriakopoulos, C., Ficz, G., Wolf, V., & Walter, J. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004905 · Cited by 23
High-Resolution ROMA CGH and FISH Analysis of Aneuploid and Diploid Breast TumorsPreprint
Hicks, J. B., Muthuswamy, L. B., Alex Krasnitz, A., Navin, N. E., Riggs, M. G., Grubor, V. D., Esposito, D., Alexander, J., Troge, J. E., Wigler, M. H., et al. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.055 · Cited by 21
Self-citationKam, Y., Das, T., Minton, S. E., & Gatenby, R. A. (2014) · Women s Health · doi:10.2217/whe.14.23 · Cited by 20
T�rnok, A., Bocsi, J., R�ssler, H., Schlykow, V., Schneider, P. M., & Hambsch, J. (2001) · Cytometry · doi:10.1002/1097-0320(20010215)46:1<50::aid-cyto1037>3.0.co;2-t · Cited by 17
Cited by
Eleven grand challenges in single-cell data science
Lähnemann, D., Köster, J., Szczurek, E., McCarthy, D. J., Hicks, S. C., Robinson, M. D., Vallejos, C. A., Campbell, K. R., Beerenwinkel, N., Mahfouz, A., et al. (2020) · Genome Biology · doi:10.1186/s13059-020-1926-6 · Cited by 1,327
Epigenetic plasticity and the hallmarks of cancer
Flavahan, W. A., Gaskell, E., & Bernstein, B. E. (2017) · Science · doi:10.1126/science.aal2380 · Cited by 1,340
“Epigenetic alterations may occur individually over time or, alternatively, may arise as multiple simultaneous disruptions, analogous to the catastrophic genetic aberrations associated with “chromothrypsis” (41, 42).”
BackgroundTumour heterogeneity and metastasis at single-cell resolution
Lawson, D. A., Kessenbrock, K., Davis, R. T., Pervolarakis, N., & Werb, Z. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0236-7 · Cited by 606
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Zhang, A., Miao, K., Sun, H., & Deng, C.-X. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72534 · Cited by 352
Metadata
- Authors
- Davis, A., Gao, R., & Navin, N.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 1867
- Issue
- 2
- Pages
- 151-161
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2579382924
- Cited by
- 352
- References
- 155
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.